TY  - GEN
AU  - Xing,Puyuan
AU  - Mu,Yuxin
AU  - Wang,Yan
AU  - Hao,Xuezhi
AU  - Zhu,Yixiang
AU  - Hu,Xingsheng
AU  - Wang,Hongyu
AU  - Liu,Peng
AU  - Lin,Lin
AU  - Wang,Zhijie
AU  - Li,Junling
TI  - Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer
SN  - 1759-7714
PY  - 2019///0212
KW  - Adult
KW  - Aged
KW  - Anaplastic Lymphoma Kinase
KW  - genetics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bevacizumab
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - ErbB Receptors
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Progression-Free Survival
KW  - Retrospective Studies
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/1759-7714.12650
ER  -